Sanofi offers VRS to 800 employees at two units in Telangana
A Sanofi spokesperson told ET that a glut of supplies added during Covid-19 and the struggle to win contracts from Unicef for its critical 5-in-1 pediatric vaccine Shan5 forced the company to assess its India operations.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Contracts | Covid Vaccine | COVID-19 | India Health | Pediatrics | Pharmaceuticals | Vaccines